本頁面由Tiger Trade Technology Pte. Ltd.提供服務

TriSalus Life Sciences Inc.

3.92
-0.0900-2.24%
盤後3.920.00000.00%16:10 EDT
成交量:18.23萬
成交額:71.32萬
市值:2.40億
市盈率:-2.13
高:4.05
開:4.00
低:3.81
收:4.01
52周最高:7.95
52周最低:3.42
股本:6,130.64萬
流通股本:5,136.20萬
量比:0.78
換手率:0.35%
股息:- -
股息率:- -
每股收益(TTM):-1.8389
每股收益(LYR):-1.8389
淨資產收益率:-496.21%
總資產收益率:-56.80%
市淨率:-7.10
市盈率(LYR):-2.13

資料載入中...

2024/03/12

重要事件披露

Form 8-K - Current report
2024/01/25

重要事件披露

Form 8-K - Current report
2024/01/05

重要事件披露

Form 8-K - Current report
2023/12/21

SEC問詢函

Form CORRESP - Correspondence
2023/12/21

SEC問詢函

Form CORRESP - Correspondence
2023/12/15

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/12/15

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/12/14

SEC問詢函

Form CORRESP - Correspondence
2023/11/14

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/14

重要事件披露

Form 8-K - Current report
2023/10/19

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/10/18

SEC問詢函

Form CORRESP - Correspondence
2023/10/16

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans
2023/10/03

重要事件披露

Form 8-K - Current report
2023/09/02

[修訂]招股説明書

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
2023/09/01

重要事件披露

Form 8-K - Current report
2023/08/31

招股説明書

Form S-1 - General form for registration of securities under the Securities Act of 1933
2023/08/29

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/23

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/08/22

超過5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals